2013•China Medicine and PharmacyRequires access

Clinical application value of lovastatin combined with Zhibituo in patients with hyperlipidemia

Shuya Wang

Abstract

Objective To investigate the Clinical application value of lovastatin combined with Zhibituo in patients with hyperlipidemia. Methods 168 cases patients with hyperlipidemia in our hospital from January 2012 to May 2013were divided into control group(lovastatin) and experimental group(lovastatin+zhibituo), the efficacy of two groups were compared after 8 weeks. Results The total effective-rate of experimental group was 90.47%,which was higher than that of control group(75.00%)(P 0.05) and the experimental group showed significantly lower level of total cholesterine, glycerine, low density lipoprotein cholesterol, TC-HDL-C/HDL-C and higher high density lipoprotein cholesterol than the control group(P 0.05). Conclusion Lovastatin combined with Zhibituo has a significant effects on treating hyperlipidemia, which is worthy of clinical widely.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Lovastatin, Hyperlipidemia, Medicine, Internal medicine, Cholesterol, Gastroenterology, Total cholesterol, High-density lipoprotein